Mersana Therapeutics OverviewMersana Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MRSN.
Quarterly EBIT
$0.00
As of Sep 30, 2025
Annual EBIT (TTM)
-$60.18M
↑ 9.63% YoY
Trailing 12 months ending Sep 30, 2025
Mersana Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for MRSN.
As of Sep 30, 2025
Trailing 12 months ending Sep 30, 2025